DESNA THERAPEUTICS Trademark

Trademark Overview

On Wednesday, September 25, 2024, a trademark application was filed for DESNA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DESNA THERAPEUTICS trademark a serial number of 98768178. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, July 16, 2026. This trademark is owned by Desna Therapeutics Inc. The DESNA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines
desna therapeutics

General Information

Serial Number98768178
Word MarkDESNA THERAPEUTICS
Filing DateWednesday, September 25, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, July 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 6, 2025

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of vaccines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2024
Primary Code042
First Use Anywhere DateFriday, November 1, 2024
First Use In Commerce DateFriday, November 1, 2024

Trademark Owner History

Party NameDesna Therapeutics Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US
Party NameDesna Therapeutics Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US

Trademark Events

Event DateEvent Description
Wednesday, September 25, 2024NEW APPLICATION ENTERED
Wednesday, September 25, 2024APPLICATION FILING RECEIPT MAILED
Sunday, March 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 31, 2025ASSIGNED TO EXAMINER
Thursday, April 3, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, April 3, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, April 3, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 3, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, April 3, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 30, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 6, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 6, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 1, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 1, 2025TEAS STATEMENT OF USE RECEIVED
Friday, March 6, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 1, 2025USE AMENDMENT FILED
Friday, March 6, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 1, 2026SU - NON-FINAL ACTION - WRITTEN
Wednesday, April 1, 2026NON-FINAL ACTION E-MAILED
Wednesday, April 1, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 16, 2026SU-EXAMINER'S AMENDMENT WRITTEN
Thursday, July 16, 2026EXAMINERS AMENDMENT E-MAILED
Thursday, July 16, 2026EXAMINER'S AMENDMENT ENTERED
Thursday, July 16, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 16, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 16, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Related Keywords

therapeutics desna vaccines development research